Hives (urticaria) are one of the most common and earliest signs of anaphylaxis. Most anaphylactic reactions involve skin symptoms, though some cases do not. Skin symptoms of anaphylaxis may ...

If a doctor identifies someone as being at risk of anaphylactic shock, they may give them an auto-injector. An auto-injector contains medication that helps to ease the symptoms in an emergency.

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

Another study examined the clinical signs and treatment responses in cases of perioperative anaphylaxis. It revealed that cardiovascular symptoms were the most prevalent, followed by skin and ...

Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.

From 1996-2024, 82 cases of anaphylaxis associated with glatiramer acetate were reported to the FDA Adverse Event Reporting ...

Teva Pharmaceutical’s Copaxone was approved by the FDA in 1996 to treat relapsing forms of MS, an autoimmune disorder that ...